Literature DB >> 1386984

Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity.

D S Hoon1, M M Kaback, J Lim-Steele, T Tsuchida, D L Morton, R F Irie.   

Abstract

GM2 is usually significantly elevated in human melanoma cells. The lysosomal hydrolase beta-hexosaminidase A (Hex A), is an isoenzyme required for terminal GalNAc hydrolysis from intact GM2 to GM3. The objective of the present studies is to determine if the elevated levels of gangliosides, particularly GM2, correlate with the activity of Hex A in cultured melanoma cells. The Hex A activity in 13 melanoma cell lines ranged from 26%-88.3% There was a inverse correlation between GM2 nmole/g and Hex A activity (r = -0.48; p less than 0.003). An inverse correlation (p less than 0.03) occurred between GD2 nmole/g and Hex A activity. There was an inverse correlation (r = -0.53; p less than 0.05 and r = -0.51; p less than 0.05, respectively) between the ratio of substrate/product (GM2/GM3) and (GD2/GD3) and Hex A activity. These results indicate that the level of GM2 in melanoma is inversely correlated with the level of activity of Hex A.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386984

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  2 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.

Authors:  Romela Irene Ramos; Matias A Bustos; Jinfeng Wu; Peter Jones; Shu Ching Chang; Eiji Kiyohara; Kevin Tran; Xiaoqing Zhang; Stacey L Stern; Sivan Izraely; Orit Sagi-Assif; Isaac P Witz; Michael A Davies; Gordon B Mills; Daniel F Kelly; Reiko F Irie; Dave S B Hoon
Journal:  Mol Oncol       Date:  2020-06-05       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.